Title : Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan.

Pub. Date : 2019 Mar

PMID : 30205936






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Rasagiline is a monoamine oxidase type-B inhibitor in development in Japan for Parkinson"s disease (PD). rasagiline monoamine oxidase B Homo sapiens